We describe an experimental procedure for the isolation of growth inhibitory sequences from a complex cDNA library. This approach ®rst takes advantage of the SETGAP technique (selectable expression of transient growth arrest phenotype) to enrich for growth inhibitory sequences, followed by a screening procedure to identify individual cDNAs that inhibit cell proliferation. Here we provide a detailed description of the experimental protocol and report the characterization of two cDNA sequences isolated in our initial screen of a mouse cDNA library. One of these cDNAs encodes the mouse ubiquitin-conjugation enzyme UbcM2. The other encodes a truncated form of a novel WD40 repeat protein, named Bop1, which is conserved from yeast to human. Together, these results demonstrate a new approach for the isolation of growth suppressors from cDNA libraries, and identify a previously unknown gene likely to be involved in growth control.
Introduction
Cell proliferation can be regulated both positively and negatively. Considerable progress has been made in understanding the mechanisms that lead to activation of the proliferative program. Recent studies have also demonstrated the existence of multiple negative control mechanisms, which can intervene at several checkpoints to prevent cell cycle progression if previous cycle events have not been properly completed (Hartwell and Weinert, 1989; Elledge, 1996; Paulovich et al., 1997) . The importance of these mechanisms is underscored by the fact that the loss of function of the proteins involved, such as p53, can lead to genetic damage and neoplasia (Donehower et al., 1992; Hartwell and Kastan, 1994; Cross et al., 1995; Harper and Elledge, 1996) . During development, most cells switch from active proliferation to nonreplicative, dierentiated state. Although growth-arrested cells constitute the majority of cells in the organism, the molecular mechanisms that establish and maintain their replicative arrest are only poorly understood.
Positive regulators of cell growth may confer a growth advantage on cells expressing them, or may indeed overpower the cellular growth control machinery and lead to uncontrolled proliferation. Consequently, a plethora of oncogenes have been identi®ed by means of retroviral transduction and gene transfer.
In contrast, the identi®cation of genes that can suppress proliferation in a dominant manner has proven more dicult. Cells expressing a gene that cause growth arrest may be eliminated from a growing culture, and these cells do not have a phenotype for which a selection can be easily applied. The use of genetic methods for studying growth-inhibitory pathways has therefore been limited.
We have recently developed a method that allows the isolation of growth-inhibitory DNA sequences by genetic selection in mammalian cells (Pestov and Lau, 1994) . This method, called SETGAP (selectable expression of transient growth-arrest phenotype), utilizes a library that potentially contains growthinhibitory sequences cloned in an inducible expression vector. After transfection into mammalian cells, expression of library DNA is transiently induced to block growth of those cells that have incorporated growth-inhibitory sequences. These cells are then isolated from the transfected population by selective killing of cells that are capable of DNA replication.
In the previous study, we tested the feasibility of SETGAP in the selection of short inhibitory fragments of a small group of known growth-related genes (Pestov and Lau, 1994) . In an eort to devise a method to identify previously unknown growthinhibitory genes, we have developed a two-step procedure based on SETGAP. Using this approach, we have isolated two cDNA clones that can reversibly arrest cell growth. One of these clones encodes a known gene, the mouse ubiquitin-conjugating enzyme UbcM2. The other encodes an amino-terminal truncated sequence of a novel gene with unknown function, bop1. Expression of both of these cDNAs in NIH3T3 ®broblasts results in a reversible inhibition of G1 progression. These results suggest that our experimental approach can be a useful strategy for identi®cation of novel growth-inhibitory genes in cDNA libraries.
Results

Genetic selection for the enrichment of growth inhibitory sequences
We have developed a two step approach to isolate growth-inhibitory cDNA clones from a complex cDNA library. First, we applied the SETGAP selection procedure (Pestov and Lau, 1994) to enrich for sequences that are capable of arresting cell growth when expressed. Second, we subjected the enriched cDNA sequences to a screening procedure to identify individual growth-inhibitory clones.
As a source of mRNA for our cDNA library, we used primary mouse embryo ®broblasts cultured according to the 3T3 regimen to the point of crisis, whereupon these cells lost their proliferative potential and took on morphological characteristics reminiscent of senescent cells (Todaro et al., 1965; Todaro and Green, 1963) . mRNA from these ®broblasts was used to prepare a cDNA library using the vector pX11, which allows IPTG-inducible expression in NIH3T3-derived LAP3 cells (Pestov and Lau, 1994 ). The cDNA library was transfected into LAP3 cells; approximately 10 4 stably transfected clones were divided into several pools and subjected to selection using a modi®ed SETGAP procedure that was adapted for a complex full-length cDNA library. The essential steps in this selection are as follows (Figure 1 ): (1) Cells that incorporate BrdU while transfected sequences are expressed under IPTG induction are selectively killed; (2) Cells that are growth-inhibited due to expression of transfected sequences survive the selective killing and are rescued by the removal of IPTG. Another cycle of IPTG induction and BrdU/light treatment can be applied to the rescued cells to reduce background; (3) Transfected cDNA sequences are recovered by PCR and recloned into pX11. Since cells rescued after one round of selection may contain multiple sequences because of cotransfection, sequences recovered from them can be pooled into secondary libraries and subjected to another round of selection to further reduce complexity. After the second round, the rescued sequences can be analysed individually.
LAP3 cells transfected with the cDNA library were treated with IPTG to induce expression of the transfected sequences, which resulted in increased survival of cells after BrdU/light treatment ( Figure  2a) . A similar increase was observed when LAP3 cells were transfected with a growth-inhibitory variant of JunB (11-11) (Pestov and Lau, 1994) , whereas cells transfected with negative controls (pX11 empty vector or pX8B6-luc) did not show a similar eect. Cells that survived one round of selection were expanded and transfected sequences were recovered by PCR, generating mixtures of products that ranged from 300 bp to 43 kb in length. The rescued sequences were subjected to another round of selection. To this end, PCR products 4700 ± 800 bp in length recovered from surviving cells from each dish were isolated from an agarose gel and recloned into pX11 to create a secondary library. Twenty secondary libraries thus obtained were transfected into LAP3 cells, generating a few thousand stable clones in each transfection. Four out of the 20 secondary libraries were positive in SETGAP selection, yielding surviving cells. The transfected sequences recovered by PCR from these cells were signi®cantly less complex than cDNAs isolated after one round of selection. However, attempts to reduce this complexity further by additional rounds of selection were unsuccessful, most likely due to unavoidable cotransfection of multiple sequences into a single cell in the calcium phosphatemediated transfection procedure.
Screening for individual growth-inhibitory cDNA clones
Sequences recovered from each of the four cell populations that survived the secondround of selection were cloned into pX11 and 30 ± 50 individual plasmid clones were isolated at random. Plasmid DNA of each clone was digested with HinfI to produce a distinct pattern to exclude identical clones from further analysis. In order to identify individual growth inhibitory sequences, we devised a screening procedure, SETGAP-2. Clones were cotransfected with a bgalactosidase marker plasmid into LAP3 cells, which were subjected to one cycle of IPTG induction and BrdU/light treatment and then stained with X-gal (technical details are provided in Materials and methods). The growth of blue colonies surviving the BrdU/light procedure indicated the growth-inhibitory potential of the transfected sequence. Using this screening method, we isolated two growth-inhibitory clones derived from two separate cell populations. The two isolated growth-inhibitory clones contained inserts of 1.2 kb (clone 23F4) and 1.75 kb (clone B5-35).
Expression of 23F4 or B5-35 inhibits cell proliferation
Expression of 23F4 or B5-35 in LAP3 cells led to a dramatic increase in the number of cells that survived the SETGAP procedure (Figure 2b ). To con®rm that this eect was due to growth inhibition, we pooled cells from approximately 10 3 stable clones derived by transfection with 23F4, B5-35 or control constructs pX11 and pX11-p27, and counted the number of cells after three days of culture in the presence or absence of IPTG (Figure 3) . Pools of transfected cells rather than clonal cell lines were examined in this experiment to Figure 1 Schematic representation of the SETGAP procedure for selection of growth-inhibitory cDNA sequences eliminate any clonal eects on growth rates. While the presence of IPTG did not signi®cantly alter the growth of cells transfected with pX11, induction of B5-35 resulted in a signi®cant decrease in the rate of cell proliferation, comparable to the eect of expression of the transfected cdk inhibitor p27Kip1 (Figure 3) . Induction of expression of 23F4 in this assay resulted in a modest inhibition of the growth rate, which was consistent with a relatively smaller eect observed in SETGAP (see Figure 2b ). When we ®rst subjected the pool of cells transfected with 23F4 to one round of SETGAP selection and used the surviving cells for the cell proliferation assay, these pre-selected cells displayed a clear reduction in their growth rate upon IPTG treatment (Figure 3 ). The observed increase in the growth-inhibitory eect after SETGAP selection likely re¯ects the enrichment in the proportion of cells that express the 23F4-encoded sequence at a suciently high level to cause growth inhibition. Parallel selection of cells transfected with the inducible p27Kip1 construct also increased the observed growth-inhibitory eect of its expression (Figure 3 ). Taken together, these results show that expression of B5-35 and 23F4, identi®ed in a SETGAP assay, can indeed inhibit proliferation in LAP3 ®broblasts.
Expression of B5-35 or 23F4 leads to G1 arrest
To investigate the nature of the growth inhibition conferred by expression of cDNA sequences in B5-35 and 23F4, we cotransfected these plasmids with pHyg into LAP3 cells and generated stable clonal lines in which expression of the transfected sequences was inducible by IPTG ( Figure 4) . We tested the eect of expression of these sequences on the ability of cells synchronized by serum starvation to initiate DNA synthesis. Several independently obtained stable lines were serum-starved and then restimulated with 10% serum in the presence of BrdU. The number of cells entering S phase was assessed by immunohistochemical staining of BrdU-positive nuclei. Induction of B5-35 and 23F4 in several tested lines inhibited the ability of cells to enter S phase, whereas no eect was observed in the control cell line transfected with the empty Figure 2 SETGAP selection for growth inhibitory cDNAs. (a). Cells were transfected with either the cDNA library (Lib), the growth-inhibitory construct 11-11 (a truncated variant of JunB) (Pestov and Lau, 1994) , or the negative control plasmids pX11 (empty vector) and pX8-luc (vector driving expression of the luciferase gene). Stable clones obtained from each transfection were pooled, and 10 5 cells from each pool were subjected to two cycles of BrdU/light treatment to kill cells that synthesize DNA. Cells were tested for survival of BrdU/light treatment either in the presence or absence of 1 mM IPTG to regulate expression of transfected sequences. After the second BrdU/light treatment, surviving cells were allowed to grow for 7 days in the absence of IPTG and then stained with crystal violet. (b) Cell survival after BrdU/light treatment upon induction of transfected sequences (+IPTG). Cells were transfected with either the negative control pX8-luc, the positive control pX11-p27 (a p27Kip1 expressing plasmid), and clones B5-35 and 23F4. Experiments were carried out as in (a), except that cells were subjected to only one cycle of BrdU/light treatment before surviving cells were rescued vector ( Figure 5 ). Expression of B5-35 (line B5-35/6) and 23F4 (line 23F4/4) blocked DNA synthesis in 80% of cells in this experiment; expression of 23F4 in another clonal line, 23F4/5, resulted in approximately 50% fewer cells undergoing DNA synthesis. In all stable cell lines examined, induction of either 23F4 or B5-35 was not apparently toxic and did not induce any noticeable increase in cell death even after a prolonged IPTG treatment.
To test whether the inhibition of S phase entry might be due to G1 arrest, we analysed the status of the retinoblastoma tumor suppressor protein (Rb), which is hyperphosphorylated prior to G1 exit, in inducible cell lines B5-35/6 and 23F4/4. These cells were synchronized by serum starvation and then stimulated with 10% serum. Induction of B5-35 with IPTG strongly inhibited Rb phosphorylation ( Figure  6 ). Although Rb phosphorylation was not inhibited in cells expressing 23F4, it was considerably delayed (compare hypophosphorylated Rb at 12 h in 23F4-expressing and -non-expressing cells). These data indicate that the antiproliferative eects of both B5-35 and 23F4 are, at least in part, due to restriction of progression through G1 prior to Rb phosphorylation.
Clone 23F4 encodes a ubiquitin-conjugation enzyme
Sequence analysis revealed that clone 23F4 encodes the entire reading frame of the mouse ubiquitin-conjugating enzyme UbcM2. Compared to the previously published UbcM2 sequence (Genebank accession no. X92664), 23F4 (Genebank accession no. AF003346) diers by a single A ? G substitution within the coding region (nucleotide 94 in 23F4) and contains a longer 3'-untranslated region. The nucleotide substitution was not due to a mutation that occurred during SETGAP selection, since it was also present in a sequence independently obtained from primary mouse fibroblasts by reverse transcription-PCR using UbcM2-speci®c primers.
To determine whether growth inhibition by deregulated expression of UbcM2 is dependent on its enzymatic activity, we created a single amino acid substitution mutant construct in which the cysteine-145 residue at the active site of this enzyme (Matuschewski et al., 1996) was replaced with a serine residue. This mutation abolished inhibition of cell growth as judged by the SETGAP assay, suggesting that it is the enzymatic function of UbcM2 that causes the growth inhibition (Figure 7) , rather than any non-productive interactions that may result from overexpression of the protein.
Clone B5-35 identi®es a novel WD40 repeat protein, Bop1
We isolated a full-length cDNA sequence corresponding to B5-35 from a mouse library as described in Materials and methods. The isolated cDNA, designated Bop1 (block of proliferation), was 2476 bp long, in agreement with the size of a single transcript detected in mouse cells. The B5-35 clone (1737 bp) initiates at nt 747 of the bop1 sequence, having deleted the 5' end (Figure 8 ). The B5-35 cDNA contains a single long open-reading frame that starts with two closely located ATG codons, the second of which (nt. 799; Figure 8 ) is in a good Kozak context. We constructed an expression vector encoding a deletion mutant, Bop1D, whose translation is initiated with this codon. Expression of Bop1D led to growth inhibitory eects indistinguishable from those of B5-35 (Figure 7) .
When tested in SETGAP, the full-length Bop1 construct inhibited proliferation of LAP3 cells, indicating that increased levels of Bop1 can induce cell cycle arrest (Figure 7) . The eect of Bop1 Inducible expression of B5-35 and 23F4 mRNA in clonal cell lines. Individual clones of LAP3 cells stably transfected with B5-35 (lines B5-35/6 and B5-35/2) or 23F4 (lines 23F4/4 and 23F4/5) were either untreated (7) or treated (+) with 1 mM IPTG for 9 h. Total RNA (2.5 mg for left panel and 1.5 mg for right panel) was analysed by Northern blotting with the corresponding cDNA probes. Lower panel: equal loading in each lane was shown by methylene blue staining of the same blot to reveal ribosomal RNAs expression, however, was not as striking as that of B5-35. The simplest interpretation of this fact is that the deletion of the amino-terminal part of Bop1 creates a gain-of-function mutant. Another possibility is that the amino-terminal deletion in B5-35 might create a dominant-negative mutant that is more potent in perturbing Bop1 function than overexpression of the full-length protein. Further studies will be needed to determine the physiologic role of Bop1 and to understand how interference with its function results in a strong, albeit reversible, block to cell cycle progression.
Database analyses revealed two sequences that are homologous to Bop1: one in human (KIAA0124), and one in the yeast S. cerevisiae (YM9796.02c) (Figure 9 ). The human KIAA0124 sequence was obtained by sequencing randomly chosen human cDNA clones and contains a partial coding sequence (Nagase et al., 1995) . The yeast sequence YM9796.02c was deduced from an open reading frame found in the genome of this organism. All three amino acid sequences are highly homologous except in their amino-termini. The deduced mouse Bop1 shares approximately 45% amino acid sequence identity with the yeast YM9796.02c, and 490% amino acid identity with the human sequence, excluding the amino-terminus (Figure 9 ). The aminoterminal domains of all three of these proteins are divergent in their primary structure, although they are very similar in composition. The most prominent feature of these domains is that they are rich in acidic and serine residues and contain PEST sequences, which are often found in short-lived regulatory proteins (Rechsteiner and Rogers, 1996) . The amino acid sequence of Bop1 contains several motifs, known as WD40 (or b-transducin) repeats (Figure 8 ), which are found in a large number of regulatory proteins (Neer et al., 1994; Neer and Smith, 1996) and may be involved in protein-protein interactions (Wall et al., 1995; Lambright et al., 1996; Sondek et al., 1996) . The WD40 motif encompasses approximately 40 amino acid residues with several conserved features, including a characteristic Trp-Asp (WD) dipeptide. All WD40 repeat proteins contain from 4 to 10 repeats that display dierent degrees of divergence from the consensus WD40 motif structure (Neer et al., 1994) . Four WD40 repeats were identi®ed in Bop1 by a pattern search against the Blocks database (Pietrokovski et al., 1996) . Repeats 1 and 4 (Figure 8 ) are close to the consensus structure, while repeats 2 and 3 are more divergent. Interestingly, repeat 3 contains a Cys residue instead of the canonical Trp (or another aromatic) residue in the marker WD dipeptide, although it gains a high score in a computer search as a true WD40 repeat due to proper positioning of other characteristic aminoacid residues.
Discussion
The SETGAP procedure was developed as a genetic approach to isolate growth-inhibitory sequences based on a functional assay in mammalian cells (Pestov and Lau, 1994) . This procedure was ®rst applied in the selection of short genetic suppressor elements targeted at a small group of known growth-related genes. In this report, we describe an adaptation of the SETGAP procedure for the cloning of growth-inhibitory cDNA sequences from a complex library. This adaption takes advantage of the genetic selection conferred by SETGAP to enrich for growth inhibitory sequences, followed by a screening procedure to identify individual clones.
We started by constructing a conditional expression cDNA library using mRNA from mouse ®broblast passaged to crisis; the cDNA library was transfected into LAP3 cells and an estimated 10 4 of the transfected clones were ®rst subjected to selection to enrich for growth-inhibitory cDNA sequences. Each of the transfected clones typically contained 10 ± 100 cDNA sequences, as judged by PCR analysis (data not shown). After two consequtive rounds of SETGAP selection, the PCR pattern of cDNA recovered from cells was simple enough to permit analysis of individual clones.
In this study, we carried out our selection and screening with a relatively small number (10 4 ) of transfected clones. Given that typically 10 ± 100 sequences are incorporated into each clone, the actual number of sequences that have been tested in this screening is much larger than the number of clones screened. However, we speculate that the two growth inhibitory cDNAs we isolated in this screening represents only a small fraction of such sequences in the library for several reasons. First, the transfected sequences must be expressed at an appropriate level under induction to cause transient growth arrest. Second, we encountered a relatively low success rate in recovery of growth-inhibitory cDNA sequences from growth-arrested cells during selection (about 20% in this study). This may be due to a loss of integrity of some cDNA sequences upon chromosomal integration, which could prevent their ampli®cation by PCR. Third, it is possible that in some cells growth arrest is caused by combinatorial or additive action of multiple sequences, and this eect may be lost when the sequences are tested individually. We also noted that some cDNA sequences chosen at random for testing were refractory to ampli®cation by Pfu, although they could be eciently ampli®ed by other enzymes. To improve the recovery of cDNA sequences from transfected cells, we now use PCR protocols that utilize a combination of polymerases.
Most of the problems that limit the ecacy of the present experimental procedure derive from the nature of transfection in mammalian cells. Perhaps a dierent method of introduction of cDNA into cells (for instance, using virus-based or episomal vectors) might improve the success rate in the selection step. Some of the aforementioned problems can be addressed by screening a larger number of clones, and in this regard, reduction of the complexity of the starting library should greatly enhance the ecacy of the procedure. Recently, highly ecient methods for normalization of cDNA libraries have been developed (de Fatima Bonaldo et al., 1996) . The signi®cantly lower overall complexity of such libraries should make it possible to analyse a large fraction of the cDNAs. Figure 7 Eects of mutations in UbcM2 and Bop1. Pools of cells stably transfected with either the empty vector (pX11), or expression constructs of UbcM2 (23F4), a cysteine-145 to serine mutation of UbcM2 (23F4mut), the full length bop1 (Bop1), and 5' deletion of bop-1 (Bop1D) were analysed in the SETGAP assay. Expression of transfected sequences was induced with IPTG, and cells were subjected to BrdU/light treatment. Growth of surviving cells was restored by IPTG removal and the resulting colonies were stained 9 days thereafter One of our original concerns in application of expression cloning for the isolation of growthinhibitory cDNA was that this approach might primarily yield cDNA clones that encode proteins that have no clear role in growth control but nevertheless cause growth inhibition when their expression is out of balance relative to other cellular components. In fact, many`structural' genes (such as actin, b-tubulin, actin-binding protein, nonhistone protein B) were isolated in yeast screens for overexpression-induced growth suppressors (Liu et al., 1992) . However, we have not identi®ed any structural gene sequences in our search for growth inhibitory sequences to date. Screening of small groups of clones (10 ± 100 sequences each) from the original cDNA library, also did not yield such sequences, even though abundant transcripts should be represented among these clones (data not shown). A possible reason for this is that previous screening procedures (such as screens in yeast) identi®ed growth-inhibitory sequences based on induction of a lethal phenotype. In contrast, the SETGAP method makes use of the formation of colonies by surviving cells, which requires two events: (i) stringent blockade of DNA replication upon induction of transfected sequences, lasting for the duration of BrdU treatment (typically 48 h), and (ii) reversal of the growth arrest when expression of transfected sequences is downregulated. Hence, factors that can slow down metabolism but incapable of causing a prolonged cell cycle block or sequences that are toxic for a cell would not be identi®ed in SETGAP. We anticipate that this feature of the SETGAP method should facilitate the identi®cation of regulatory genes. In support of this idea, tests with several known genes capable of arresting the cell cycle in a reversible manner showed that they can be readily identi®ed by the SETGAP procedure (for example, see results with p27Kip1, Figure 2b) .
The two growth-inhibitory cDNAs isolated in this study were 1.2 and 1.75 kb in length. Since the majority of the mRNAs in the cell are between 1 ± 2 kb, we expect that many growth-inhibitory cDNA sequences can be successfully recovered using the present experimental protocol. One of the isolated clones, 23F4, encoded a full coding sequence of UbcM2, while clone B5-35 contained a partial deletion of Bop1 cDNA, which fortuitously created a very strong growth-inhibitory sequence. The isolation of partial cDNA fragments is not surprising, as many clones in any cDNA library are products of incomplete cDNA synthesis. Although this may initially appear a disadvantage, the isolation of Figure 9 Comparison of amino acid sequences of the murine Bop1 and its human (KIAA0124) and yeast (YM9796.02c) homologs. Alignment was compiled using the Clustal W program (Thompson et al., 1994) and modi®ed by using GeneDoc (Nicholas et al., 1997) . Shading indicates identical positions and conservative substitutions truncated cDNA sequences in a selection for growth inhibition can also be informative. For instance, identi®cation of dominant negative variants of regulatory genes essential for cell replication could reveal practical ways to inactivate such genes. It is conceivable that some partial cDNAs isolated by this method could encode activated forms of growthinhibitory proteins. In this regard, we note that many of the genes identi®ed by their ability to induce cell transformation in traditional gene transfer experiments represent activated forms of their normal cellular variants.
The speci®c cellular processes aected by overexpression of the uniquitin-conjugating enzyme UbcM2 (clone 23F4) that can lead to inhibition of cell cycle progression are currently unknown. The ubiquitin degradation system is known to regulate a variety of cellular processes (Liu et al., 1992; Hochstrasser, 1995) , including the turnover of many proteins that control cell growth, including cyclins (Seufert et al., 1995) , c-Myc (Ciechanover et al., 1991) , p53 (Schener et al., 1993; Maki et al., 1996) and others (Bai et al., 1996; Schneider et al., 1996) . UbcM2 belongs to a group of evolutionarily conserved ubiquitin-conjugating enzymes of the E2 class with dierent amino-terminal extensions (Matuschewski et al., 1996) . Overexpression of UbcM2 in yeast can partially suppress de®ciency of UBC4 and UBC5 (Hochstrasser, 1995) , which are involved in stress response and degradation of regulatory and abnormal proteins (Seufert and Jentsch, 1990 ; Chen et al., 1993) . These data suggest that enzymatic activity of UbcM2 could aect degradation of a regulatory protein(s) whose activity is critical for cell cycle progression.
The B5-35 sequence encodes a fragment of a novel WD40-containing protein, Bop1, truncated from the amino-terminus. Interestingly, expression of this truncated form caused a stronger cell cycle arrest than overexpression of the full-length cDNA. Additional studies will be needed to determine the mechanism of the growth-inhibitory activity associated with expression of Bop1 and whether the B5-35 clone acts by a dominant-positive or negative mechanism with regard to the full-length clone. Several lines of observation suggest that Bop1 may function as a regulatory protein. First, all other WD40 proteins studied to date have been implicated in regulatory activities (Neer et al., 1994; Neer and Smith, 1996) . Second, the presence of PEST sequences suggests that Bop1 may be short-lived, also pointing to possible regulatory functions (Rechsteiner and Rogers, 1996) . Finally, the structural conservation of Bop1 from yeast to human suggests that function of this protein may also be conserved in diverse eukaryotic cells.
In summary, we have developed a method for the isolation of growth-inhibitory cDNAs from cDNA libraries. This experimental procedure could ®nd application in identi®cation of new cell cycle inhibitors and discovery of antiproliferative genes that may regulate the resting state in quiescent and senescent cells. This genetic strategy could potentially yield a class of growth-inhibitory molecules that would be dicult or impossible to isolate based on biochemical studies of known regulatory pathways.
Materials and methods
Cell culture
Cell culture. LAP3 cells (Pestov and Lau, 1994) , an NIH3T3 cells-derived cell line which constitutively expresses the IPTG-regulated transactivator protein LAP267 (Baim et al., 1991) , were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% calf serum (Hyclone) and penicillin-streptomycin (GIBCO-BRL). Cells were transfected by the calcium phosphate coprecipitation method (Chen and Okayama, 1988 ) using 2.5 mg of library DNA or 0.5 mg of a speci®c construct, 0.5 mg of pHyg (Sugden et al., 1985 ) and 2.5 ± 4.5 mg of carrier NIH3T3 DNA per 60-mm dish. Stable clones were selected in 130 ± 150 mg/ml 71 hygromycin (Boehringer Mannheim). Expression of transfected constructs was induced by the addition of 1 ± 1.5 mM IPTG (dioxanefree, Sigma) to culture medium.
Plasmids
The inducible vector pX11 designed for low background expression, the inducible luciferase reporter pX8B6-luc and growth-inhibitory clone 11-11 (a fragment of junB) have been described previously (Pestov and Lau, 1994) . The murine cyclin/cdk inhibitor p27(Kip1) was cloned into pX11 to generate pX11-p27; induction of this construct with IPTG inhibited growth of LAP3 cells (Shiyanov et al., 1997) .
Construction of the inducible cDNA library
Mouse embryo ®broblasts were derived from gestational day 17 embryos of Swiss mice by standard techniques (Loo et al., 1989) . The cells were passaged according to the 3T3 regimen (Todaro and Green, 1963 ) in DMEM containing 10% calf serum and penicillin-streptomycin. Cells were counted at each passage to monitor the decline in replicative potential. At the beginning of the crisis stage, their RNA was isolated by the guanidinium isothiocyanate method (Chomczynski and Sacchi, 1987) . Poly(A) RNA was puri®ed using PolyATtract System (Promega).
cDNA synthesis was carried out using reagents from the SuperScript system (GIBCO-BRL) with several modi®cations to the manufacturer's protocol. Prior to cDNA synthesis, two oligonucleotides, N3 (CTAGCTGCGGACGAACATTACA) and BR3 (CCGGAATTCGCATGAGAGTATA), were designed to incorporate partial NheI and BspEI sites (underlined) into the 5' and 3' ends of the cDNA, respectively. These primers were later used in PCR rescue of cDNA sequences from transfected cells. The ®rst cDNA strand was synthesized from 5 mg of poly(A) RNA using 200 pmoles of GA-BR3-T16 primer ((GA) 7 TCCGGAATTCGCATGAGA-GTATA(T) 16 ). A nucleotide mixture containing 10 mM each of dATP, dGTP and dTTP (Pharmacia) and 6 mM of 5-methyl-dCTP (Boehringer Mannheim) was used instead of the 10 mM dNTP mixture supplied with the SuperScript kit. After the ®rst strand synthesis, dCTP was added to 400 mM for the second strand synthesis. Ligation of double-stranded cDNA with N3 adapters and phosphorylation were performed according to the SuperScript system protocol. The cDNA was then digested with Kpn2I (an isoschizomer of BspE I that does not cut methylated DNA), extracted with phenol-chloroform and size fractionated on a Sephacryl S-500 column supplied with the kit. The resulting cDNA was ligated into pX11 digested with NheI and BspEI. Approximately 8610 5 bacterial colonies were obtained by electroporation of DH10B cells (GIBCO-BRL) with the ligated cDNA. The colonies from 35 plates were scraped into 100 ml of SOB medium and incubated with shaking at 308C for 1 h. The plasmid DNA was isolated using standard techniques.
The library was estimated to contain 45610 5 clones with an average insert size of 1.2 ± 1.5 kb.
BrdU/light selection of growth-arrested cells 10 5 stably transfected LAP3 cells were plated into a 10-cm dish in medium containing 1 mM IPTG to induce expression of sequences cloned into pX11. After 24 h, BrdU (Sigma) was added to a ®nal concentration of 10 mM and cells were cultured for 2 days. Hoechst 33258 (Sigma) was then added to 10 mg/ml 71 for 1 h and cells were irradiated with visible light for 10 min as described previously (Pestov and Lau, 1994) . Alternatively, a 10 min incubation with 1 mg/ml 71 Hoechst 33342 (Calbiochem), which was as eective as the longer treatment with Hoechst 33258, was used. The medium was removed after irradiation and cells were rinsed and refed with fresh medium. Medium was changed on days 2 and 4 after irradiation to remove dead cells.
Rescue of transfected DNA from cells after selection
Cells that survived BrdU/light selection were grown for 8 ± 10 days until they formed small colonies. Genomic DNA was isolated using DNAzol reagent (Molecular Research Center, Inc.) followed by additional treatment with RNase A prior to PCR ampli®cation with Pfu (Stratagene), a high ®delity polymerase (Lundberg et al., 1991; Bej and Mahbubani, 1994) . DNA was ®rst ampli®ed using M5 and P3 primers, which¯ank the cloning site in the pX11 vector (Pestov and Lau, 1994) , and then reampli®ed with N3 and BR3 primers. PCR was carried out in a Robocycler (Stratagene) using the following program: initial denaturation at 998C for 10 s; cycling at 998C for 20 s, 508C (M5 and P3 primers) or 558C (N3 and BR3 primers) for 40 s, 688C for 6 min. These parameters allowed ecient ampli®cation of sequences of up to 4 kb. After 16 ± 18 cycles of PCR with M5 and P3 primers, 1 ± 2 ml from this reaction was directly used in a second-step PCR with N3 and BR3. The number of cycles in this PCR was determined empirically for each template, since it dramatically aected the outcome of the reaction. Increasing the number of cycles often shifted the bias of ampli®cation toward smaller fragments. Although supplying additional Pfu polymerase (1.25 U per 25 ml reaction) helped alleviate this problem, it was important to keep the number of cycles to a minimum, enough to only visualize DNA after electrophoresis of a 5 ml aliquot (1/5 ± 1/10 of the total reaction volume) on an agarose gel.
PCR products were extracted with phenol-chloroform and puri®ed using Microcon-100 concentrators (Amicon), followed by treatment with T4 polynucleotide kinase and then with exoIII (Kaluz et al., 1992) to expose NheI and BspEI ends. This DNA was separated on a low melting point agarose gel; fragments larger than 700 ± 800 bp were puri®ed from the agarose using GELase (Epicentre) and ligated into pX11 DNA that had been digested with NheI and BspEI and dephosphorylated. For isolation of secondary libraries, 410 4 bacterial colonies obtained by electroporation of DH10B cells were scraped from plates, and processed as described above for the primary library. Individual clones were isolated using Qiawell-8 system (Qiagen).
Screening for growth-inhibitory clones (`SETGAP-2')
LAP3 cells grown in a 6-well cluster were cotransfected with a cDNA clone to be tested and pGK-b-gal. After transfection, cells were kept in the same well. After 5 ± 6 days, cells were trypsinized and split into two dishes (1/5 of cells from one well to one 100 mm dish). The waiting period before starting the assay was necessary to relieve non-speci®c growth inhibition immediately after transfection. One dish was kept without further treatment and used to control the transfection efficiency by staining the cells with X-gal. To the second dish, IPTG was added and BrdU/light treatment was performed as described above. Five or 6 days after this treatment, cells were stained with X-gal. Cells were washed once with PBS, ®xed with cold 0.5% glutaraldehyde in PBS, rinsed twice with PBS and incubated for 2 ± 3 h at 378C in staining solution (1 mM MgCl 2 , 3.3 mM of each K 4 Fe(CN) 6 and K 3 Fe(CN) 6 , 0.1% X-gal and 0.02% NP-40 in PBS).
Other analytical methods
To analyse Rb phosphorylation, cells were lysed in a buer containing 50 mM Tris-HCl (pH 8), 0.5% NP-40, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 50 mM NaF, 1 mM sodium orthovanadate and protease inhibitor cocktail (Sigma) for 30 min at 48C followed by centrifugation for 10 min at 10 000 g. Lysates (*50 mg of total protein) were ®rst concentrated by immunoprecipitation and then analysed by immunoblotting using the G3-245 antibody (Pharmingen). Detection of secondary horseradish peroxidase-coupled antibodies (Amersham) was performed with the LumiGLO reagents (KPL).
For immunohistochemical determination of BrdU incorporation, cells cultured in Falcon Culture Slides were ®xed with cold 70% ethanol and allowed to air-dry. Slides were rehydrated in water for 30 min, treated with 2N HCl for 30 min, rinsed with 0.2 M Tris-HCl (pH 8), PBST (0.2% Tween-20 in PBS), blocked with 10% fetal calf serum in PBST for 10 min, washed twice with PBST, incubated for 1 h with peroxidase-conjugated anti-BrdU antibodies (Boehringer Mannheim), washed three times with PBST, stained using DAB-Plus kit (Zymed), counterstained with hematoxylin and covered with 70% glycerol. The percentage of BrdU-labeled cells was determined using a light microscope.
Cloning and sequence analysis
Nucleotide sequences were determined using Sequenase (USB) and EXCEL (Epicentre) reagent kits and protocols. To clone the full-length Bop1 cDNA, the cDNA library described above was screened with a B5-35 probe, and the longest isolated clone of 2345 bp (designated a8) was sequenced. Both B5-35 and a8 clones contained poly(A) tails at their 3' ends at almost identical positions (six extra nucleotides were present in B5 ± 35). The sequence of B5-35 diered from the corresponding fragment of the library-derived clone a8 by a single base substitution (C?T at nt 791 resulting in a Ala?Val change; Figure 8 ). The 5' end of the cDNA was cloned using the 5' Rapid Ampli®cation of cDNA ends (RACE) System (GIBCO BRL). The sequence of a8 was combined with 131 bases derived by sequencing several independent 5' RACE clones into a sequence of 2476 bp. This sequence is likely to contain the full coding sequence since it corresponds in size to the Bop1 transcript, contains an in-frame initiating ATG and in-frame termination codon upstream. The sequences of clone 23F4 and full-length Bop1 have been deposited into the Genebank (accession numbers AF003346 and U77415, respectively). An expression construct for Bop1D was created by using PCR primers to synthesize the bop1 cDNA that initiated with nt 799 of the bop1 sequence (Figure 8 ), resulting in a 5' truncation. The sequence of the truncated bop1 was con®rmed by sequence determination, and cloned in pX11. A cysteine-145?serine mutation (23F4Mut) in UbcM2 was created by a T?A transversion at nt 436 of the 23F4 sequence.
